Zobrazeno 1 - 10
of 19
pro vyhledávání: '"N O, Opoku"'
Autor:
Daphne Lew, Sithembele Chithenga, Christopher L. King, Gary J. Weil, Augustine R. Hong, Peter Fischer, Michael E. Gyasi, Felix Doe, N. O. Opoku
Publikováno v:
The American journal of tropical medicine and hygiene. 106(2)
Mass administration of ivermectin (IVM) has significantly reduced onchocerciasis prevalence, intensity, and morbidity in most endemic areas. Most IVM clinical trials were performed long ago in persons with high-intensity infections that are uncommon
Autor:
N. O. Opoku, Bjarne Styrishave, Jørgen A. L. Kurtzhals, Michael F. Ofori, Kwadwo A. Koram, Edem W. Sarbah, Lars Hviid, Filip C. Castberg
Publikováno v:
Castberg, F C, Sarbah, E W, Koram, K A, Opoku, N, Ofori, M F, Styrishave, B, Hviid, L & Kurtzhals, J A L 2018, ' Malaria causes long-term effects on markers of iron status in children : a critical assessment of existing clinical and epidemiological tools ', Malaria Journal, vol. 17, no. 1, 464 . https://doi.org/10.1186/s12936-018-2609-6
Malaria Journal, Vol 17, Iss 1, Pp 1-12 (2018)
Malaria Journal
Malaria Journal, Vol 17, Iss 1, Pp 1-12 (2018)
Malaria Journal
BackgroundMost epidemiological studies on the interplay between iron deficiency and malaria risk classify individuals as iron-deficient or iron-replete based on inflammation-dependent iron markers and adjustment for inflammation by using C-reactive p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11d3449b332f11e45ef8cc8ae1fe7397
https://curis.ku.dk/ws/files/212904242/s12936_018_2609_6.pdf
https://curis.ku.dk/ws/files/212904242/s12936_018_2609_6.pdf
Autor:
George Olipoh, Amos Nyathirombo, Mupenzi Mumbere, Safari L Masembe, Annette C. Kuesel, N. O. Opoku, Fatorma Bolay, Sampson Asare, Didier K. Bakajika, Kpehe M Bolay, Kambale Kataliko, Jemmah P Larbelee, Simon K. Attah, Hayford Howard, Germain L Mambandu, Maurice M. Nigo, Eric M Kanza, Christine M Halleux, Kambale Kasonia, Mawolo Kpawor, Michel Vaillant
Publikováno v:
Lancet (London, England)
Summary Background The morbidity and socioeconomic effects of onchocerciasis, a parasitic disease that is primarily endemic in sub-Saharan Africa, have motivated large morbidity and transmission control programmes. Annual community-directed ivermecti
Autor:
Sara Lustigman, Christian Bottomley, Simon K. Attah, Martin Walker, María-Gloria Basáñez, Annette C. Kuesel, Valerie Isham, N. O. Opoku, Sarai Vivas-Martínez
Publikováno v:
Parasites & Vectors, Vol 10, Iss 1, Pp 1-2 (2017)
Parasites & Vectors
Parasites & Vectors
In a Letter to the Editor, Eberhard et al. question the validity of our model of skin snip sensitivity and argue against the use of skin snips to evaluate onchocerciasis elimination by mass drug administration. Here we discuss their arguments and com
Autor:
Lea Barfod, Simon J. Draper, Margaret Kweku, Frederica D. Partey, Sarah E. Silk, Edem W. Sarbah, Gordon A. Awandare, Lars Hviid, Filip C. Castberg, N. O. Opoku, Michael F. Ofori
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0204452 (2018)
PLoS ONE
PLoS ONE
Plasmodium falciparum PfRH5 protein binds Ripr, CyRPA and Pf113 to form a complex that is essential for merozoite invasion of erythrocytes. The inter-genomic conservation of the PfRH5 complex proteins makes them attractive blood stage vaccine candida
Publikováno v:
Parasites & Vectors
Elimination of onchocerciasis in Africa is now regarded as an achievable goal in many areas. This makes monitoring changes in infection prevalence a key component of control programmes. Monitoring is currently based on determining the presence of O.
Autor:
Simon K. Attah, Martin Walker, Kwablah Awadzi, Annette C. Kuesel, Hugo C. Turner, N. O. Opoku, María-Gloria Basáñez
Publikováno v:
Parasites & Vectors
Background Spurred by success in several foci, onchocerciasis control policy in Africa has shifted from morbidity control to elimination of infection. Clinical trials have demonstrated that moxidectin is substantially more efficacious than ivermectin
Autor:
Kwablah Awadzi, Daniel A. Boakye, Geoffrey Edwards, K. Ahmed, B. T. Quartey, Boakye A. Boatin, Janis K. Lazdins-Helds, Simon K. Attah, E. T. Addy, N. O. Opoku
Publikováno v:
Annals of Tropical Medicine & Parasitology. 98:359-370
The pathogenesis of the sub-optimal response of Onchocerca volvulus to ivermectin was investigated in a 30-month follow-up of 28 individuals who, in a previous study, had been found to show a sub-optimal (N = 15) or adequate response (N = 13) to mult
Autor:
B. T. Quartey, Simon K. Attah, A. E. Ardrey, Kwablah Awadzi, E. T. Addy, B. O. L. Duke, Geoffrey Edwards, N. O. Opoku
Publikováno v:
Annals of Tropical Medicine & Parasitology. 97:165-178
A randomized, double-blind, placebo-controlled trial was conducted, to determine whether the co-administration of ivermectin with albendazole is safe and more effective against Onchocerca volvulus than ivermectin alone, and whether a significant phar
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 8, Iss 6, p e2953 (2014)
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases
Background Control of onchocerciasis as a public health problem in Africa relies on annual mass ivermectin distribution. New tools are needed to achieve elimination of infection. This study determined in a small number of Onchocerca volvulus infected